BACKGROUND:The cutoff of semi-quantitative immunochemical faecal occult blood tests (iFOBTs) influences colonoscopy referrals and detection rates. We studied the performance of an iFOBT (OC-Sensor) in colorectal cancer (CRC) screening at different cutoffs. METHODS: Dutch screening participants, 50 -75 years of age, with average CRC risk and an iFOBT value X50 ng ml À1 were offered colonoscopy. The detection rate was the percentage of participants with CRC or advanced adenomas (X10 mm, X20% villous, high-grade dysplasia). The number needed to scope (NNTScope) was the number of colonoscopies to be carried out to find one person with CRC or advanced adenomas. RESULTS: iFOBT values X50 ng ml À1 were detected in 526 of 6157 participants (8.5%) and 428 (81%) underwent colonoscopy. The detection rate for advanced lesions (28 CRC and 161 with advanced adenomas) was 3.1% (95% confidence interval: 2.6 -3.5%) and the NNTScope was 2.3. At 75 ng ml À1 , the detection rate was 2.7%, the NNTScope was 2.0 and the CRC miss rate compared with 50 ng ml À1 was o5% (N ¼ 1). At 100 ng ml À1 , the detection rate was 2.4% and the NNTScope was o2. Compared with 50 ng ml À1 , up to 200 ng ml À1 CRC miss rates remained at 16% (N ¼ 4). CONCLUSIONS: Cutoffs below the standard 100 ng ml À1 resulted in not only higher detection rates of advanced lesions but also more colonoscopies. With sufficient capacity, 75 ng ml À1 might be advised; if not, up to 200 ng ml À1 CRC miss rates are acceptable compared with the decrease in performed colonoscopies.